The latest at MBC Biolabs
The latest at MBC Biolabs
CellFE Raises $3.6M in Seed Round
Read online article at YAHOO finance SAN CARLOS, Calif., Jan. 16, 2020 /PRNewswire/ -- CellFE, [...]
Mammoth Biosciences Raises $45 Million For Crispr Diagnostics
And Its Tech Is Already Being Used Against Coronavirus Mammoth Biosciences is a MBC BioLabs [...]
How a biotech incubator is helping Big Pharma punch ‘golden tickets’ for startups
By Ron Leuty – Staff Reporter, San Francisco Business Times Dec 9, 2019, 2:16pm PST Read [...]
LogicInk appears on “The World According to Jeff Goldblum”, new series on Disney+
MBC BioLabs resident company, LogicInk, appeared on the Disney+ streaming platform, as par [...]
Astellas and MBC BioLabs Announce 2019 Golden Ticket Competition
Apply for the Golden Ticket until October 11, 2019.
Celgene and MBC BioLabs Announce 2019 Golden Ticket Competition
Apply for the Golden Ticket until August 16, 2019.
Co-founder and CEO of Mammoth Biosciences on Fortune’s 2019 40 Under 40
Trevor Martin Courtesy of Molly Jorgensen - Mammoth Biosciences Mammoth Biosciences came t [...]
An early taste of Wild Type Salmon
Wild Type’s lab-grown salmon product. Source: Wild Type Inc. Read original article by Lyd [...]
Announcing Winners of the 2019 AMGEN Golden Ticket
Regencor and Nitrome Biosciences have each been awarded an Amgen Golden Ticket to MBC BioLabs
Announcing Winner of the 2019 Servier Golden Ticket
The 2019 Servier Golden Ticket at MBC BioLabs has been awarded to Quartz Therapeutics.
Apply for the 2019 AMGEN Golden Ticket by 5/3/2019!
AMGEN and MBC BioLabs invite you to apply for the 2019 AMGEN Golden Ticket!
MBC BioLab’s first company, Alector, is getting ready to go public
Alector moved into MBC BioLabs on the day we opened our doors, and now just over five year [...]
Cypre and Molecular Devices sign co-marketing agreement to collaborate on delivering solutions for screening biologically relevant assays
Kolin Hribar, PhD, CEO and Founder of Cypre Inc. with their Symphony®/VersaGel® Cypre and [...]
Announcing Recipients of the Golden Ticket Program
Nitrome Biosciences and SyntheX are the recipients of the MBC 2018 Golden Ticket program sponsored by Celgene Corporation.
Peninsula Alzheimer’s fighter hunts $150 million IPO
Alector's Arnon Rosenthal (left) and Sabah Oney. TODD JOHNSON | SAN FRANCISCO BUSINESS TIMES [...]
Prellis Biologics and CELLINK Sign Partnership
Prellis Biologics and CELLINK Sign Partnership Prellis Biologics and CELLINK sign partnersh [...]
Mammoth Biosciences Featured on Forbes 30 Under 30
Mammoth Biosciences Featured on Forbes 30 Under 30 Congratulations to Trevor Martin, CEO of [...]
Golden Ticket Offered
MBC BioLabs, the premier Bay Area life-science incubator, will present its Golden Ticket programs this year as well as future initiatives at MBC BioLabs through a sponsorship from Celgene.
Mammoth Biosciences raises $23M for its CRISPR-based disease detection engine
After completing their graduate work at Stanford, Trevor Martin and Ashley Tehranchi took 2 benc [...]
MBC BioLabs’ new San Carlos site has now welcomed fourteen companies
We launched the first phase of our new campus in San Carlos on May 1, and we have now on-boarded [...]
LI-COR places flagship infrared imaging system in San Francisco and San Carlos
Expanding the capabilities of our FastTrack Core, LI-COR has placed their Odyssey CLx infrared im [...]
Female Founders in Science
On June 26, Reshma Khilnani (Co-CEO, Droplet Health) hosted a standing-room-only panel discussion [...]
Implantable 3D-printed organs could be coming sooner than you think
by Jonathan Shieber @jshieber, June 25, 2018Read article at TechcrunchAt MBC Biolabs, an incubato [...]
Announcing the winners of the AMGEN Golden Ticket
Delve Therapeutics and Mitokinin have won the Amgen Golden Ticket at MBC BioLabs. Each company receives one year of lab bench space and more.